Clinical trial Recruiting at 1 site Interventional Ages 15 to 22

Group schema therapy for adolescents with borderline symptoms

Official title: The Effectiveness of Group Schema Therapy Utilizing Video Material in the Treatment of Borderline Symptoms in Adolescents: A Randomized and Controlled Intervention Study

Run by Turku University Hospital · NCT06606002 · Data updated 2026-11-12

This program will test whether group schema therapy using self-recorded video exercises helps adolescents aged 15–18 with borderline symptoms compared with usual care.

Quick facts

Study typeInterventional
Ages15 Years to 22 Years
SexAll
Enrollment64 (estimated)
SponsorTurku University Hospital
Government
Locations1 site (Turku, Southwest Finland)
StatusRecruiting
StartedAugust 1, 2025
Main results expectedDecember 2027
Study endsDecember 2029
Registry record updatedAugust 21, 2026
Trial IDNCT06606002 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adolescents aged 15–18 treated at Turku University Hospital who meet at least three SCID‑II criteria for borderline personality disorder, can attend sessions and complete materials in Finnish, and are not at high suicide risk are ideal candidates.

Probably not a fit

Adolescents with active psychosis, serious suicide risk, intellectual disability, autism spectrum disorder, primary substance use disorders, or those unable to participate in Finnish or attend sessions are unlikely to benefit from this program.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a randomized, controlled intervention in which about 64 adolescents (aged 15–18) are assigned to either group schema therapy or treatment as usual. The therapy follows the Farrell & Shaw group schema model and includes 30 group sessions, 8 individual sessions, and parent group meetings, with an experiential VideoTalk component using self-recorded videos. Participants are recruited from the Adolescent Psychiatry Clinic at Turku University Hospital and must meet at least three SCID-II criteria for borderline personality disorder; those with psychosis, serious suicide risk, intellectual disability, autism spectrum disorder, or primary substance use disorders are excluded. Outcomes compare symptom change and functioning between the schema therapy and usual-care groups over the course of the intervention.

Why it matters

Potential benefit: If successful, the intervention could reduce borderline symptoms and improve emotional regulation, daily functioning, and relationships for adolescents.

How similar studies have gone: Group schema therapy and the Farrell & Shaw model have shown promise in adults with BPD, but randomized evidence in adolescents is limited, so this application to teens is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* The participant fulfills at least three diagnostic criteria for borderline personality disorder as assessed by means of the SCID-II structured clinical interview
* The participant and the participant's parent(s) are able to commit to the research protocol for the entire duration of the study
* The participant is able to participate in a research intervention in Finnish and fill out the study questionnaires in Finnish

Exclusion Criteria:

* The participant currently has psychotic symptoms or a serious risk of suicide
* The participant has been diagnosed with an intellectual disability or an autism spectrum disorder
* The main clinical diagnosis of the participant is a substance abuse disorder or substance use would endanger commitment to the research intervention
* The participant has another illness or symptom that endangers the participant's ability to complete the study
* The participant receives some other treatment specifically aimed at borderline personality disorder symptoms

Where it's running

  • Turku University Hospital
    Turku, Southwest Finland, Finland
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.